Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
Read the full text
Authors: John B. Chambers, Bernard Prendergast, Bernard Iung, Raphael Rosenhek, Jose Luis Zamorano, Luc A. Piérard, Thomas Modine, Volkmar Falk, Arie Pieter Kappetein, Phillipe Pibarot, Thoralf Sundt, Helmut Baumgartner, Jeroen. J. Bax, Patrizio Lancellotti
Introduction: The increasing number of patients with heart valve disease and the wider range of therapeutic options now available, demands the standardisation of organisational structures.1,2 The ‘heart valve clinic’ is already established as a specialist outpatient clinic3,4 linked with multidisciplinary inpatient care as well as education and training. Recent international guidelines extend this specialist concept to a ‘Heart Valve Centre of Excellence’1 or ‘Heart Valve Centre’.2 These centres were proposed in order that durable mitral valve repair could be virtually guaranteed at close to zero risk in patients with asymptomatic severe mitral regurgitation caused by prolapse. The intention was that invasive valve interventions should not occur outside Heart Valve Centres. The standards defining such a centre have not previously been described and this is the purpose of this document. A Heart Valve Centre includes a heart valve clinic, but also multidisciplinary heart teams for thecare of patients with mitral valve disease, tricuspid valve disease, diseases of the aorta and aortic valve and infective endocarditis (Table 1).
Authors: Patrizio Lancellotti, Raphael Rosenhek, Philippe Pibarot, Bernard Iung, Catherine M. Otto, Pilar Tornos, Erwan Donal, Bernard Prendergast, Julien Magne, Giovanni La Canna, Luc A. Piérard, and Gerald Maurer
First published online: January 4, 2013
Background: With an increasing prevalence of patients with valvular heart disease (VHD), a dedicated management approach is needed. The challenges encountered are manifold and include appropriate diagnosis and quantification of valve lesion, the organisation of adequate follow-up, and making the right management decisions, in particular with regard to the timing and choice of interventions. Data from the Euro Heart Survey have shown a substantial discrepancy between guidelines and clinical practice in the field of VHD and many patients are denied surgery despite having clear indications. The concept of heart valve clinics (HVCs) is increasingly recognised as the way to proceed. At the same time, very few centres have developed such expertise, indicating that specific recommendations for the initial development and subsequent operating requirements of an HVC are needed.
Aims: The aim of this position paper is to provide insights into the rationale, organisation, structure, and expertise needed to establish and operate an HVC. Although the main goal is to improve the clinical management of patients with VHD, the impact of HVCs on education is of particular importance: larger patient volumes foster the required expertise among more senior physicians but are also fundamental for training new cardiologists, medical students, and nurses. Additional benefits arise from research opportunities resulting from such an organised structure and the delivery of standardised care protocols.
Conclusion: The growing volume of patients with VHD, their changing characteristics, and the growing technological opportunities of refined diagnosis and treatment in addition to the potential dismal prognosis if overlooked mandate specialised evaluation and care by dedicated physicians working in a specialised environment that are called the HVC.
Authors: Raphael Rosenhek (corresponding author), Bernard Iung, Pilar Tornos, Manuel J. Antunes, Bernard D. Prendergast, Catherine M. Otto, Arie Pieter Kappetein, Janina Stepinska, Jens J. Kaden, Christoph K. Naber, Esmeray Acartürk and Christa Gohlke-Bärwolf
First published online: March 15, 2011, Reference: Eur Heart J (2011) doi: 10.1093/eurheartj/ehr061
Aims: Risk scores provide an important contribution to clinical decision-making, but their validity has been questioned in patients with valvular heart disease (VHD) since current scores have been mainly derived and validated in adults undergoing coronary bypass surgery. The Working Group on Valvular Heart Disease of the European Society of Cardiology reviewed the performance of currently available scores when applied to VHD, in order to guide clinical practice and future development of new scores.
Methods and results: The most widely used risk scores (EuroSCORE, STS, and Ambler score) were reviewed, analysing variables included and their predictive ability when applied to patients with VHD. These scores provide relatively good discrimination, i.e. a gross estimation of risk category, but cannot be used to estimate the exact operative mortality in an individual patient because of unsatisfactory calibration.
Conclusion: Current risk scores do not provide a reliable estimate of exact operative mortality in an individual patient with VHD. They should, therefore, be interpreted with caution and only used as part of an integrated approach, which incorporates other patient characteristics, the clinical context, and local outcome data. Future risk scores should include additional variables, such as cognitive and functional capacity and be prospectively validated in high-risk patients. Specific risk models should also be developed for newer interventions, such as transcatheter aortic valve implantation.
Authors: B. Iung, C. Gohlke-Barwolf, P. Tornos, C. Tribouilloy, R. Hall, E. Butchart and A. Vahanian
Published online: 2002 Reference: European Heart Journal (2002) 23, 1253–1266, doi:10.1053/euhj.2002.3320
Abstract: The management of asymptomatic patients with valve disease has become an important medical problem. There are two main reasons for this: firstly such patients are currently being diagnosed more frequently because of the widespread availability of echocardiography; secondly, the opportunity to perform less invasive interventions is an incentive to intervene earlier. However, data concerning the management of asymptomatic patients are limited. For this reason, this topic remains a particularly rich source of debate.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved